About
Diagnostics
Areas of Focus
Categories
DiagnosticsChina
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
7
As Collaborator
6
Total Enrollment
19,056
By Phase
NA: 3
By Status
UNKNOWN: 4COMPLETED: 4RECRUITING: 3ACTIVE_NOT_RECRUITING: 1NOT_YET_RECRUITING: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT06065527Collaborator
Future Planning and Well-Being for Individuals With Intellectual Disabilities and Family Caregivers
NARecruiting
1,050 participants
Started: Dec 22, 2023 · Completed: Apr 30, 2029
NCT06174727Collaborator
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
N/ARecruiting
5,000 participants
Started: Oct 1, 2023 · Completed: Dec 31, 2025
NCT05783297Collaborator
Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence
NAActive, not recruiting
600 participants
Started: Apr 17, 2023 · Completed: Aug 31, 2025
NCT05494853Lead Sponsor
Novel Biomarker Assay for Biomarker Assay for HCC Detection
N/ANot yet recruiting
200 participants
Started: Dec 1, 2022 · Completed: Dec 1, 2025
NCT05237037Collaborator
Assessment of Sleep Quality in Cannabinoid Therapy
N/AUnknown
34 participants
Started: Aug 22, 2022 · Completed: Aug 31, 2023
Locations (1)
Headquarters
Beijing, China
Map
Loading map...